These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3683201)

  • 1. Isolation of the BSC-1 monkey kidney cell growth inhibitor.
    Holley RW; Baldwin JH; Greenfield S
    Methods Enzymol; 1987; 146():163-7. PubMed ID: 3683201
    [No Abstract]   [Full Text] [Related]  

  • 2. A growth regulatory factor that can both inhibit and stimulate growth.
    Holley RW; Baldwin JH; Greenfield S; Armour R
    Ciba Found Symp; 1985; 116():241-52. PubMed ID: 3878272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of kidney epithelial cell growth inhibitors.
    Holley RW; Böhlen P; Fava R; Baldwin JH; Kleeman G; Armour R
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5989-92. PubMed ID: 6969400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid selective effects by a growth inhibitor and epidermal growth factor on the incorporation of [35S]methionine into proteins secreted by African green monkey (BSC-1) cells.
    Nilsen-Hamilton M; Holley RW
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5636-40. PubMed ID: 6604275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-[(3-cholamidopropyl)dimethylammonio]-1-propane sulfonate as noncytotoxic stabilizing agent for growth factors.
    Matuo Y; Nishi N; Matsumoto K; Miyazaki K; Matsumoto K; Suzuki F; Nishikawa K
    Methods Enzymol; 1991; 198():511-8. PubMed ID: 1857239
    [No Abstract]   [Full Text] [Related]  

  • 6. Epithelins 1 and 2: isolation and characterization of two cysteine-rich growth-modulating proteins.
    Shoyab M; McDonald VL; Byles C; Todaro GJ; Plowman GD
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7912-6. PubMed ID: 2236009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The growth inhibitor of African green monkey (BSC-1) cells is transforming growth factors beta 1 and beta 2.
    McPherson JM; Sawamura SJ; Ogawa Y; Dineley K; Carrillo P; Piez KA
    Biochemistry; 1989 Apr; 28(8):3442-7. PubMed ID: 2742846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor.
    Tucker RF; Shipley GD; Moses HL; Holley RW
    Science; 1984 Nov; 226(4675):705-7. PubMed ID: 6093254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant responses to growth-regulatory signals by variant kidney epithelial cells.
    Walsh-Reitz MM; Feldman RI; Toback FG
    Am J Physiol; 1988 May; 254(5 Pt 2):F747-53. PubMed ID: 3364581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of recombinant melanoma growth stimulating activity.
    Thomas HG; Han JH; Balentien E; Derynck R; Bordoni R; Richmond A
    Methods Enzymol; 1991; 198():373-83. PubMed ID: 1857230
    [No Abstract]   [Full Text] [Related]  

  • 11. Purification of amphiregulin from serum-free conditioned medium of 12-O-tetradecanoylphorbol 13-acetate-treated cell lines.
    Shoyab M; Plowman GD
    Methods Enzymol; 1991; 198():213-21. PubMed ID: 1857220
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions between the growth effects of a kidney epithelial cell growth inhibitor and extracellular concentrations of cyclic nucleotides.
    Fremuth F; Holley RW; Baldwin JH
    Neoplasma; 1982; 29(3):295-300. PubMed ID: 6290910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and properties of epithelial growth inhibitor (EGI) from human platelets: its separation from type beta transforming growth factor (TGF-beta).
    Huang W; Kimura T; Mashima K; Miyazaki K; Masaki H; Yamashita J; Horio T
    J Biochem; 1986 Sep; 100(3):687-96. PubMed ID: 3465720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and properties of growth inhibitor from normal rabbit serum.
    Kimura T; Miyazaki K; Mashima K; Yamashita J; Horio T; Kakuno T
    J Biochem; 1991 Sep; 110(3):423-8. PubMed ID: 1769970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like synergistic stimulation of DNA synthesis in Swiss 3T3 cells by the BSC-1 cell-derived growth inhibitor related to transforming growth factor type beta.
    Brown KD; Holley RW
    Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3743-7. PubMed ID: 3295869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from the nucleotide sequence of the cDNA.
    Hanks SK; Armour R; Baldwin JH; Maldonado F; Spiess J; Holley RW
    Proc Natl Acad Sci U S A; 1988 Jan; 85(1):79-82. PubMed ID: 3277172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast factor inducing leukemic cell differentiation and inhibiting malignant cell growth.
    Rogalsky V; Zinzar S; Golub E; Den T
    Ann N Y Acad Sci; 1991; 628():323-5. PubMed ID: 2069313
    [No Abstract]   [Full Text] [Related]  

  • 18. Separation of melanoma growth stimulatory activity and human type-alpha transforming growth factor.
    Richmond A; Thomas HG; Roy RG
    Methods Enzymol; 1987; 146():112-26. PubMed ID: 3479673
    [No Abstract]   [Full Text] [Related]  

  • 19. BSC-1 growth inhibitor/type beta transforming growth factor is a strong inhibitor of thymocyte proliferation.
    Ristow HJ
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5531-3. PubMed ID: 3488549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BSC-1 growth inhibitor transforms a mitogenic stimulus into a hypertrophic stimulus for renal proximal tubular cells: relationship to Na+/H+ antiport activity.
    Fine LG; Holley RW; Nasri H; Badie-Dezfooly B
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6163-6. PubMed ID: 2994063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.